Expert clinical management of autoimmune hepatitis in the real world

Autor: R. Liberal, Y. S. de Boer, R. J. Andrade, G. Bouma, G. N. Dalekos, A. Floreani, D. Gleeson, G. M. Hirschfield, P. Invernizzi, M. Lenzi, A. W. Lohse, G. Macedo, P. Milkiewicz, B. Terziroli, B. van Hoek, J. M. Vierling, M. A. Heneghan, on behalf of the International Autoimmune Hepatitis Group (IAIHG), A. Pares, A. J. Montano-Loza, A. Granito, A. E. Kremer, C. Schramm, C. Lammert, E. L. R. Cancado, E. Bjornsson, F. Lammert, G. M. Hirschflield, H. Hofer, I. Mackay, J. Neuberger, J. P. H. Drenth, C. M. J. van Nieuwkerk, L. Muratori, M. Swain, M. Heneghan, M. Zeniya, O. Chazouilleres, P. Gines, R. Chapman, T. Berg, H. van Buuren, X. Ma

Publikováno v: Liberal, R, de Boer, Y S, Andrade, R J, Bouma, G, Dalekos, G N, Floreani, A, Gleeson, D, Hirschfield, G M, Invernizzi, P, Lenzi, M, Lohse, A W, Macedo, G, Milkiewicz, P, Terziroli, B, van Hoek, B, Vierling, J M, Heneghan, M, Pares, A, Montano-Loza, A J, Granito, A, Kremer, A E, Floreani, A, Lohse, A W, van Hoek, B, Terziroli, B, Schramm, C, Lammert, C, Cancado, E L R, Bjornsson, E, Lammert, F, Dalekos, G N, Bouma, G, Hirschflield, G M, Macedo, G, Hofer, H, Mackay, I, Neuberger, J, Vierling, J M, Drenth, J P H, van Nieuwkerk, C M J, Muratori, L, Lenzi, M, Swain, M, Heneghan, M, Zeniya, M, Chazouilleres, O, Gines, P, Milkiewicz, P, Andrade, R J, Ma, X & the International Autoimmune Hepatitis Group (IAIHG) 2017, ' Expert clinical management of autoimmune hepatitis in the real world ', Alimentary Pharmacology and Therapeutics, vol. 45, no. 5, pp. 723-732 . https://doi.org/10.1111/apt.13907
Alimentary Pharmacology and Therapeutics, 45(5), 723-732
Alimentary Pharmacology & Therapeutics, 45, 723-732
Alimentary Pharmacology & Therapeutics, 45, 5, pp. 723-732

none 55 si First published: 22 December 2016 Background: High-quality data on the management of autoimmune hepatitis (AIH) are scarce. Despite published guidelines, management of AIH is still expert based rather than evidence based. Aim: To survey ex

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d91175f447c75f0806a630fa90b826e1
https://hdl.handle.net/2066/169664

Overview of hepatitis B and transplantation in the hepatitis B patient

Autor: G, Garcia, L M, Petrovic, J M, Vierling

Publikováno v: Seminars in liver disease. 20

Hepatitis B is a disease that infects 300,000 people in the United States each year, resulting in 15,000-30,000 cases of chronic hepatitis. Outcomes include death; development of chronic carrier state, chronic hepatitis, fibrosis, cirrhosis, and hepa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::10cc43705f8fd07a1c3eff476e91eaeb
https://pubmed.ncbi.nlm.nih.gov/10895437

Posttransplantation: future therapies

Autor: M G, Peters, D, Shouval, A, Bonham, J M, Vierling, A S, Lok

Publikováno v: Seminars in liver disease. 20

Recent advances in prophylaxis and treatment of hepatitis B virus (HBV) infection after liver transplantation have improved the outcome of liver transplantation for hepatitis B. Currently, the long-term use of hepatitis B immune globulin (HBIG) and/o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::912fb7af7d098e155b995367e5038922
https://pubmed.ncbi.nlm.nih.gov/10895440

Old and new immunosuppressant drugs: mechanisms and potential value

Autor: J. M. Vierling

Publikováno v: Primary Biliary Cirrhosis ISBN: 9789401060479

Primary biliary cirrhosis (PBC) is a chronic, progressive cholestatic liver disease that predominantly affects women. It is characterized by inflammatory destruction of interlobular and septal bile ducts, periportal hepatitis, septal fibrosis and ult

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5966a3a16e4b90ddd6c6e7c9e260ec9a
https://doi.org/10.1007/978-94-011-4884-9_14

Recurrence of viral hepatitis after liver transplantation: insights into management

Autor: F G, Villamil, J M, Vierling

Publikováno v: Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 1(5 Suppl 1)

Recurrence of viral infection and hepatitis is a common problem for patients undergoing LT for hepatitis B or hepatitis C. In patients with hepatitis B who do not receive immunoprophylaxis, recurrence of HBsAg positivity is virtually universal and is

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1ebbe898a97343ee709310fe3dfec9a3
https://pubmed.ncbi.nlm.nih.gov/9346605